Reeve Emma sold PTCT
December 3, 2025 · Form 4 insider transaction
Reeve Emma sold 733 shares of PTC Therapeutics, Inc. at $78.62 per share, a transaction worth $57.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
733
Price
$78.62
Total value
$57.6K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 3, 2025
Filing dateDecember 5, 2025
Shares owned after6,666
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.